The Michigan Prostate Score (MiPS) test combines serum PSA with the mRNA expression levels of the abovementioned PCA3 gene, and the TMPRSS2-ERG gene fusion (specific for PCa), in post-DRE urine specimens. The gene discussed is TMPRSS2; the disease is posterior cortical atrophy.